The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm [0.03%]
JAK2 V617F等位基因负担有助于费城染色体阴性 myeloproliferativeneoplasm 诊断区分
Sang Hyuk Park,Hyun-Sook Chi,Young-Uk Cho et al.
Sang Hyuk Park et al.
Background: We aimed to evaluate the feasibility of using the allele burden of Janus kinase 2 (JAK2) V617F as a criterion for discriminating 3 subtypes of Philadelphia chromosome-negative myeloproliferative neoplasm (Ph(-...
CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma [0.03%]
经典霍奇金淋巴瘤中CD163和c-Met的表达及血清游离轻链水平升高与不同临床病理参数之间的关系分析
Magdy Bedewy,Shereen El-Maghraby,Ahmed Bedewy
Magdy Bedewy
Background: Advances in the understanding of Hodgkin's lymphoma (HL) show various functions of infiltrating immune cells and cytokines in relation to clinical outcomes. The expression of CD163 and c-Met has been suggested...
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry [0.03%]
韩国淋巴瘤工作组登记中心网络数据弥漫性大B细胞淋巴瘤患者的临床特征及生存分析
Hyeon Gyu Yi,Jin Seok Kim,Cheolwon Suh et al.
Hyeon Gyu Yi et al.
Background: This study aimed to survey the clinical spectrum of diffuse large B-cell lymphoma (DLBCL) in terms of epidemiology, pathologic subtypes, stage, and prognostic index as well as treatment outcomes. ...
Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions [0.03%]
人骨髓间充质干细胞培养条件不同基因表达模式也不同
Myoung Woo Lee,Dae Seong Kim,Keon Hee Yoo et al.
Myoung Woo Lee et al.
Background: Because of the heterogeneity of human mesenchymal stem cells (MSCs), methods for cell expansion in culture and the effects on gene expression are critical factors that need to be standardized for preparing MSC...
Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma [0.03%]
帕米膦酸钠治疗急性淋巴细胞白血病和非霍奇金淋巴瘤化疗期间及化疗后骨密度低患儿的有效性研究
Jae Min Lee,Ji Eun Kim,Soon Hwan Bae et al.
Jae Min Lee et al.
Background: Reduced bone mineral density (BMD) is a significant sequelae in children receiving chemotherapy for acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Reduced BMD is associated with an increase...
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations [0.03%]
关于地西他滨治疗骨髓增生异常综合征的争议及实用性建议
Yoo-Jin Kim,Jun Ho Jang,Jae-Yong Kwak et al.
Yoo-Jin Kim et al.
Azacitidine is recommended for patients with higher-risk myelodysplastic syndromes (MDS) who are not eligible for intensive therapy or for patients with lower-risk MDS who have thrombocytopenia or neutropenia or have anemia that is unrespon...
Woan-Sang Kim,Sangho Lee,Young-Sup Yoon
Woan-Sang Kim
While bone marrow (BM)-derived cells have been comprehensively studied for their propitious pre-clinical results, clinical trials have shown controversial outcomes. Unlike previously acknowledged, more recent studies have now confirmed that...
Sang Hyuk Park,Hyun-Sook Chi
Sang Hyuk Park
Case Reports
Blood research. 2013 Jun;48(2):75. DOI:10.5045/br.2013.48.2.75 2013
Internuclear bridging [0.03%]
核间性联系
Antonio La Gioia,Mina Hur
Antonio La Gioia
Case Reports
Blood research. 2013 Jun;48(2):74. DOI:10.5045/br.2013.48.2.74 2013
Plerixafor use for peripheral blood stem cell mobilization in Korea [0.03%]
plerixafor在韩国外周血干细胞动员中的应用
Seok Jin Kim,Dok Hyun Yoon,Deok-Hwan Yang et al.
Seok Jin Kim et al.